Scott Schlackman
Insider
First SEC filing: June 18, 2020 · Latest: June 18, 2020
Insider at
Insider transactions
2 buys (P)
0 sells (S)
Net: $62,950
Avg return of open purchases vs now: -6.8%
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | MED | A | 11,680 | · | · | 42,229 Direct | +38.23% | Acquired | (price as of 2026-10-02) |
| May 11, 2026 | MED | P | 2,500 | $12.53 | $31,325 | 30,549 Direct | +8.91% | Acquired | -6.4% (price as of 2026-10-02) |
| May 8, 2026 | MED | P | 2,500 | $12.65 | $31,625 | 28,049 Direct | +9.79% | Acquired | -7.3% (price as of 2026-10-02) |
| June 25, 2025 | MED | A | 11,168 | · | · | 25,549 Direct | +77.66% | Acquired | (price as of 2026-10-02) |
| June 20, 2024 | MED | A | 6,596 | · | · | 14,381 Direct | +84.73% | Acquired | (price as of 2026-10-02) |
| March 8, 2024 | MED | M | 1,300 | $27.68 | $35,984 | 11,838 Direct | +12.34% | Acquired | -57.6% (price as of 2026-10-02) |
| March 8, 2024 | MED | S | 1,300 | $39.41 | $51,233 | 10,538 Direct | -10.98% | Disposed | -70.2% (price as of 2026-10-02) |
| March 8, 2024 | MED | S | 2,753 | $39.46 | $108,633 | 7,785 Direct | -26.12% | Disposed | -70.3% (price as of 2026-10-02) |
| March 8, 2024 | MED | M | 1,300 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 7, 2023 | MED | P | 53 | $68.89 | $3,651 | 10,538 Direct | +0.51% | Acquired | -83.0% (price as of 2026-10-02) |
| Aug. 8, 2023 | MED | P | 40 | $89.42 | $3,577 | 10,485 Direct | +0.38% | Acquired | -86.9% (price as of 2026-10-02) |
| June 15, 2023 | MED | A | 3,152 | · | · | 10,445 Direct | +43.22% | Acquired | (price as of 2026-10-02) |
| May 9, 2023 | MED | P | 13 | $87.50 | $1,138 | 7,293 Direct | +0.18% | Acquired | -86.6% (price as of 2026-10-02) |
| March 10, 2023 | MED | M | 2,200 | $27.68 | $60,896 | 9,480 Direct | +30.22% | Acquired | -57.6% (price as of 2026-10-02) |
| March 10, 2023 | MED | S | 2,200 | $108.68 | $239,096 | 7,280 Direct | -23.21% | Disposed | -89.2% (price as of 2026-10-02) |
| March 10, 2023 | MED | M | 2,200 | · | · | 1,300 Direct | -62.86% | Disposed | (price as of 2026-10-02) |
| Feb. 7, 2023 | MED | P | 10 | $114.97 | $1,150 | 7,280 Direct | +0.14% | Acquired | -89.8% (price as of 2026-10-02) |
| Nov. 8, 2022 | MED | P | 10 | $106.93 | $1,069 | 7,270 Direct | +0.14% | Acquired | -89.0% (price as of 2026-10-02) |
| Aug. 8, 2022 | MED | A | 8 | $138.78 | $1,110 | 7,260 Direct | +0.11% | Acquired | -91.5% (price as of 2026-10-02) |
| June 16, 2022 | MED | A | 1,448 | · | · | 7,252 Direct | +24.95% | Acquired | (price as of 2026-10-02) |
| June 3, 2021 | MED | A | 669 | · | · | 5,804 Direct | +13.03% | Acquired | (price as of 2026-10-02) |
| June 3, 2021 | MED | A | 669 | · | · | 5,900 Direct | +12.79% | Acquired | (price as of 2026-10-02) |
| May 19, 2021 | MED | S | 904 | $310.09 | $280,321 | 5,231 Direct | -14.74% | Disposed | -96.2% (price as of 2026-10-02) |
| May 19, 2021 | MED | S | 96 | $311.57 | $29,911 | 5,135 Direct | -1.84% | Disposed | -96.2% (price as of 2026-10-02) |
| June 16, 2020 | MED | A | 1,699 | · | · | 6,135 Direct | +38.30% | Acquired | (price as of 2026-10-02) |
| June 4, 2020 | MED | M | 1,500 | $27.68 | $41,520 | 7,555 Direct | +24.77% | Acquired | -57.6% (price as of 2026-10-02) |
| June 4, 2020 | MED | S | 1,619 | $107.35 | $173,800 | 5,936 Direct | -21.43% | Disposed | -89.1% (price as of 2026-10-02) |
| June 4, 2020 | MED | S | 1,500 | $107.77 | $161,655 | 4,436 Direct | -25.27% | Disposed | -89.1% (price as of 2026-10-02) |
| June 4, 2020 | MED | M | 1,500 | · | · | 3,500 Direct | -30.00% | Disposed | (price as of 2026-10-02) |
| March 8, 2019 | MED | S | 990 | $131.21 | $129,898 | 6,055 Direct | -14.05% | Disposed | -91.1% (price as of 2026-10-02) |
| March 8, 2019 | MED | S | 1,010 | $130.64 | $131,946 | 7,045 Direct | -12.54% | Disposed | -91.0% (price as of 2026-10-02) |
| March 5, 2019 | MED | M | 2,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 5, 2019 | MED | S | 2,500 | $129.80 | $324,500 | 8,055 Direct | -23.69% | Disposed | -91.0% (price as of 2026-10-02) |
| March 5, 2019 | MED | M | 2,500 | $28.59 | $71,475 | 10,555 Direct | +31.04% | Acquired | -59.0% (price as of 2026-10-02) |
| Feb. 22, 2019 | MED | A | 1,054 | · | · | 8,055 Direct | +15.05% | Acquired | (price as of 2026-10-02) |
| Feb. 7, 2018 | MED | A | 1,619 | · | · | 7,001 Direct | +30.08% | Acquired | (price as of 2026-10-02) |
| Feb. 16, 2017 | MED | A | 2,639 | · | · | 5,382 Direct | +96.21% | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2016 | MED | A | 5,000 | · | · | 7,500 Direct | +200.00% | Acquired | (price as of 2026-10-02) |
| Feb. 4, 2016 | MED | A | 2,118 | · | · | 2,743 Direct | +338.88% | Acquired | (price as of 2026-10-02) |
| Sept. 15, 2015 | MED | A | 2,500 | · | · | 2,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 15, 2015 | MED | A | 625 | · | · | 625 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 8, 2024 | MED | Stock Option (Right to Buy) | Common Stock | $27.68 | Feb. 4, 2026 | 1,300 | Disposed |
| March 10, 2023 | MED | Stock Option (Right to Buy) | Common Stock | $27.68 | Feb. 4, 2026 | 2,200 | Disposed |
| June 4, 2020 | MED | Stock Option (Right to Buy) | Common Stock | $27.68 | Feb. 4, 2026 | 1,500 | Disposed |
| March 5, 2019 | MED | Stock Options | Common Stock | $28.59 | Feb. 17, 2025 | 2,500 | Disposed |
| Feb. 4, 2016 | MED | Stock Option | Common Stock | $27.68 | Feb. 4, 2026 | 5,000 | Acquired |
| Sept. 15, 2015 | MED | Stock Option | Common Stock | $28.59 | Feb. 17, 2025 | 2,500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).